Cargando…
Review of Diagnostic Biomarkers in Autoimmune Pancreatitis: Where Are We Now?
Autoimmune pancreatitis (AIP) is a pancreatic manifestation of an IgG4-related disease (IgG4-RD). AIP lacks disease-specific biomarkers, and therefore, it is difficult to distinguish AIP from malignancies, especially pancreatic cancer. In this review, we have summarized the latest findings on potent...
Autores principales: | Yokode, Masataka, Shiokawa, Masahiro, Kodama, Yuzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8146865/ https://www.ncbi.nlm.nih.gov/pubmed/33923064 http://dx.doi.org/10.3390/diagnostics11050770 |
Ejemplares similares
-
“Diagnostic and Prognostic Biomarkers of Luminal Breast Cancer: Where are We Now?”
por: Höller, Anna, et al.
Publicado: (2023) -
Colorectal Cancer Biomarkers: Where Are We Now?
por: Gonzalez-Pons, Maria, et al.
Publicado: (2015) -
Clinical review: Biomarkers of acute kidney injury: where are we now?
por: Ostermann, Marlies, et al.
Publicado: (2012) -
Cardiac MRI in Autoimmune Diseases: Where Are We Now?
por: Vallianou, Natalia G., et al.
Publicado: (2021) -
EUS-FNA in cystic pancreatic lesions: Where are we now and where are we headed in the future?
por: Lariño-Noia, Jose, et al.
Publicado: (2018)